Abstract
Neuropeptide Y (NPY), a 36-amino-acid neuropeptide is the most potent physiological appetite transducer known. Episodic NPY neurosecretion in hypothalamic target sites is temporally linked with onset of the daily feeding pattern. Upregulation of NPY signaling in the arcuate nucleus-paraventricular nucleus (ARC-PVN) neural axis is responsible for the hyperphagia evoked by dieting, fasting, hormonal and genetic factors, and disruption in intrahypothalamic signaling. Clusters of NPY-producing neurons in the ARC that coexpress γ-amino butyric acid and agouti-related peptide, and those in the brain stem (BS) that coexpress catecholamines and galanin, participate in disparate manners to regulate appetitive behavior. NPY receptors, Y1, Y2, and Y5, expressed by various components of the NPY network, mediate NPY-induced feeding. Imbalance in NPY signaling due either to high or low abundance of NPY at target sites elicits hyperphagia leading to increased fat accretion and obesity. Recent studies show that intermittent, feedback action of opposing afferent hormonal signals—leptin from adipose tissue and ghrelin from stomach—regulate the episodic secretion of orexigenic NPY in the PVN-ARC. Apparently, the hypothalamic NPY network is the primary common pathway intimately involved in genesis of appetite-stimulating impulses.
Similar content being viewed by others
References
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., and Kalra, P. S. (1999). Endocr. Rev. 20, 68–100.
Kalra, S. P. and Kalra, P. S. (2003). In: Encyclopedia of hormones. Henry, H. L. and Norman, A. W. (eds.). Academic Press: San Diego, CA.
Kalra, S. P. and Kalra, P. S. (2003). Regul. Pept. 111(1–3), 1–11.
Broberger, C. and Hokfelt, T. (2001). Physiol. Behav. 74, 669–682.
Comuzzie, A. G. and Allison, D. B. (1998). Science 280, 1374–1377.
Inui, A. (2000). Pharmacol. Rev. 52, 35–61.
Leibel, R. L., Chung, W. K., and Chua, S. C., Jr. (1997). J. Biol. Chem. 272, 31937–31940.
Bray, G. A. (1998) In: Handbook of obesity. Marcel Dekker: New York, vol. 1, pp. 1–29.
Bray, G. A. (1984). Int. J. Obes. 8, 119–137.
Hetherington, A. W. and Ranson, S. W. (1940). The Anatomical Record 78, 149–172.
Anand, B. K. and Brobeck, J. R. (1951). The Yale J. Biol. Med. 24, 123–146.
Clark, J. T., Kalra, P. S., Crowley, W. R., and Kalra, S. P. (1984). Endocrinology 115, 427–429.
Sahu, A., Kalra, P. S., and Kalra, S. P. (1988). Peptides 9, 83–86.
Kalra, S. P., Clark, J. T., Sahu, A., Dube, M. G., and Kalra, P. S. (1988). Synapse 2, 254–257.
Kalra, S. P., Clark, J. T., Sahu, A., Kalra, P. S., and Crowley, W. R. (1989). In: Neuropeptide Y. Hokfelt, T., Lundberg, J. D., Mutt, V., and Fuxe, K. (eds.). Raven Press: New York, pp. 229–242.
Horvath, T. L., Diano, S., and van den Pol, A. N. (1998). 28th Annual Meeting for the Society of Neuroscience, Los Angeles, CA.
Sakurai, T., Amemiya, A., Ishii, M., et al. (1998). Cell 92, 573–585.
Skofitsch, G., Jacobowitz, D. M., and Zamir, N. (1985). Brain Res. Bull. 15, 635–649.
Ludwig, D. S., Tritos, N. A., Mastaitis, J. W., et al. (2001). J. Clin. Invest. 107, 379–386.
Jain, M. R., Horvath, T. L., Kalra, P. S., and Kalra, S. P. (2000). Regul. Pept. 87, 19–24.
Dube, M. G., Horvath, T. L., Kalra, P. S., and Kalra, S. P. (2000). Peptides 21, 1557–1560.
Chaffer, C. L. and Morris, M. J. (2002). Endocrinology 143, 191–197.
Friedman, J. M. and Halaas, J. L. (1998). Nature 395, 763–770.
Bowers, C. Y. (2001). J. Clin. Endocrinol. Metab. 86, 1464–1469.
Kalra, S. P. and Kalra, P. S. (1990). In: Current topics in neuroendocrinology. Pfaff, D. W. and Ganten, D. (eds.). Springer-Verlag: Berlin, vol. 10, pp. 192–197.
Kalra, S. (1996). Curr. Opin. Endocrinol. Diabetes 3, 157–163.
Larhammar, D., Wraith, A., Berglund, M. M., Holmberg, S. K., and Lundell, I. (2001). Peptides 22, 295–307.
Clark, J. T., Kalra, P. S., and Kalra, S. P. (1985). Endocrinology 117, 2435–2442.
Kalra, S. P., Dube, M. G., and Kalra, P. S. (1988). Peptides 9, 723–728.
Zarjevski, N., Cusin, I., Vettor, R., Rohner-Jeanrenaud, F., and Jeanrenaud, B. (1993). Endocrinology 133, 1753–1758.
Stanley, B. G., Chin, A. S., and Leibowitz, S. F. (1985). Brain Res. Bull. 14, 521–524.
Dumont, T., Jacques, D., St. Pierre, J. A., and Quirion, R. (1997). In: Neuropeptide Yand drug development. Grundermar, L. and Bloom, S. (eds.). Academic Press: New York, pp. 57–86.
Hokfelt, T., Broberger, C., Zhang, X., et al. (1998). Brain Res. Brain Res. Rev. 26, 154–166.
Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P., and Kalra, P. S. (1991). Proc. Natl. Acad. Sci. USA 88, 10931–10935.
Dube, M. G., Sahu, A., Kalra, P. S., and Kalra, S. P. (1992). Endocrinology 131, 684–688.
Sahu, A., Sninsky, C. A., Phelps, C. P., Dube, M. G., Kalra, P. S., and Kalra, S. P. (1992). Endocrinology 131, 2979–2985.
Yokosuka, M., Xu, B., Pu, S., Kalra, P. S., and Kalra, S. P. (1998). Physiol. Behav. 64, 331–338.
Yokosuka, M., Kalra, P. S., and Kalra, S. P. (1999). Endocrinology 140, 4494–4500.
Yokosuka, M., Dube, M. G., Kalra, P. S., and Kalra, S. P. (2001). Peptides 22, 507–514.
Kopp, J., Xu, Z. Q., Zhang, X., et al. (2002). Neuroscience 111, 443–532.
Campbell, R. E., ffrench-Mullen, J. M., Cowley, M. A., Smith, M. S., and Grove, K. L. (2001). Neuroendocrinology 74, 106–119.
Dube, M. G., Xu, B., Crowley, W. R., Kalra, P. S., and Kalra, S. P. (1994). Brain Res. 646, 341–344.
Daniels, A. J., Matthews, J. E., Slepetis, R. J., et al. (1995). Proc. Natl. Acad. Sci. USA 92, 9067–9071.
Daniels, A. J., Grizzle, M. K., Wiard, R. P., Matthews, J. E., and Heyer, D. (2002). Regul. Rept. 106, 47–54.
Kanatani, A., Ito, J., Ishihara, A., et al. (1998). Regul. Pept. 75–76, 409–415.
Gerald, C., Walker, M. W., Criscione, L., et al. (1996). Nature 382, 168–171.
Sahu, A., White, J. D., Kalra, P. S., and Kalra, S. P. (1992). Brain Res. Mol. Brain Res. 15, 15–18.
Xu, B., Kalra, P. S., Farmerie, W. G., and Kalra, S. P. (1999). Endocrinology 140, 2868–2875.
Xu, B., Kalra, P. S., Moldawer, L. L., and Kalra, S. P. (1998). Regul. Pept. 25, 75–76:391-395.
Xu, B., Dube, M. G., Kalra, P. S., et al. (1998). Endocrinology 139, 466–473.
Lambert, P. D., Anderson, K. D., Sleeman, M. W., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 4652–4657.
Erickson, J. C., Clegg, K. E., and Palmiter, R. D. (1996). Nature 381, 415–421.
Erickson, J. C., Hollopeter, G., and Palmiter, R. D. (1996). Science 274, 1704–1707.
Bannon, A. W., Seda, J., Carmouche, M., et al. (2000). Brain Res. 868, 79–87.
Sindelar, D. K., Mystkowski, P., Marsh, D. J., Palmiter, R. D., and Schwartz, M. W. (2002). Diabetes 51, 778–783.
Hidaka, S., Yoshimatsu, H., Kondou, S., et al. (2001). J. Neurochem. 77, 993–1000.
Bonavera, J. J., Dube, M. G., Kalra, P. S., and Kalra, S. P. (1994). Endocrinology 134, 2367–2370.
Sar, M., Sahu, A., Crowley, W. R., and Kalra, S. P. (1990). Endocrinology 127, 2752–2756.
Harris, H. A., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2002). Endocrinology 143, 4172–4177.
Sahu, A., Dube, M. G., Kalra, S. P., and Kalra, P. S. (1988). Peptides 9, 1269–1273.
Sahu, A., Kalra, S. P., Crowley, W. R., and Kalra, P. S. (1988). Brain Res. 457, 376–378.
Kalra, P. S., Dube, M. G., Xu, B., and Kalra, S. P. (1997). Regul. Pept. 72, 121–130.
Kalra, P. S., Dube, M. G., Xu, B., Farmerie, W. G., and Kalra, S. P. (1998). Physiol. Behav. 63, 829–835.
Dube, M. G., Kalra, P. S., Crowley, W. R., and Kalra, S. P. (1995). Brain Res. 690, 275–278.
Dube, M. G., Xu, B., Kalra, P. S., Sninsky, C. A., and Kalra, S. P. (1999). Brain Res. 816, 38–46.
Dube, M. G., Pu, S., Kalra, S. P., and Kalra, P. S. (2000). Peptides 21, 793–801.
Koyama, K., Shimabukuro, M., Chen, G., et al. (1998). J. Clin. Invest. 102, 728–733.
Pu, S., Dube, M. G., Xu, B., Kalra, S. P., and Kalra, P. S. (1998). 80th Annual Meeting of the Endocrine Society, New Orleans, LA.
Everitt, B. J. and Hokfelt, T. (1989). In: Neuropeptide Y. Mutt, V., Fuxe, K., Hokfelt, T., and Lundberg, J. (eds.). Raven Press: New York, pp. 61–72.
Holets, V. R., Hokfelt, T., Rokaeus, A., Terenius, L., and Goldstein, M. (1988). Neuroscience 24, 893–906.
Allen, L. G., Kalra, P. S., Crowley, W. R., and Kalra, S. P. (1985). Life Sci. 37, 617–623.
Hahn, T. M., Breininger, J. F., Baskin, D. G., and Schwartz, M. W. (1998). Nat. Neurosci. 1, 271–272.
Horvath, T. L., Bechmann, I., Naftolin, F., Kalra, S. P., and Leranth, C. (1997). Brain Res. 756, 283–286.
Pu, S., Jain, M. R., Horvath, T. L., Diano, S., Kalra, P. S., and Kalra, S. P. (1999). Endocrinology 140, 933–940.
Ollmann, M. M., Wilson, B. D., Yang, Y. K., et al. (1997). Science 278, 135–138.
White, J. D. and Kernshaw, M. (1990). Mol. Cell. Neurosci. 1, 41–48.
Mizuno, T. M. and Mobbs, C. V. (1999). Endocrinology 140, 814–817.
Leonhardt, S., Shahab, M., Luft, H., Wuttke, W., and Jarry, H. (1999). J. Neuroendocrinol. 11, 613–619.
Horvath, T. L., Naftolin, F., Kalra, S. P., and Leranth, C. (1992). Endocrinology 131, 2461–2467.
Horvath, T. L., Kalra, S. P., Naftolin, F., and Leranth, C. (1995). J. Neuroendocrinol. 7, 579–588.
Horvath, T. L., Naftolin, F., Leranth, C., Sahu, A., and Kalra, S. P. (1996). Endocrinology 137, 3069–3078.
Garcia de Yebenes, E., Li, S., Fournier, A., St-Pierre, S., and Pelletier, G. (1995). Brain Res. 674, 112–116.
Morley, J. E. (1987). Endocr. Rev. 8, 256–287.
Kristensen, P., Judge, M. E., Thim, L., et al. (1998). Nature 393, 72–76.
Kalra, P. S., Norlin, M., and Kalra, S. P. (1995). Brain Res. 705, 353–356.
Blasquez, C., Jegou, S., Feuilloley, M., Rosier, A., Vandesande, F., and Vaudry, H. (1994). Endocrinology 135, 2759–2764.
Jegou, S., Blasquez, C., Delbende, C., Bunel, D. T., and Vaudry, H. (1993). Ann. NY Acad. Sci. 680, 260–278.
Cowley, M. A., Pronchuk, N., Fan, W., et al. (1999). Neuron 24, 155–163.
Cowley, M. A., Smart, J. L., Rubinstein, M., et al. (2001). Nature 411, 480–484.
Kalra, S. P., Dube, M. G., Fournier, A., and Kalra, P. S. (1991). Physiol. Behav. 50, 5–9.
Broberger, C., Landry, M., Wong, H., Walsh, J. N., and Hokfelt, T. (1997). Neuroendocrinology 66, 393–408.
Kushi, A., Sasai, H., Koizumi, H., Takeda, N., Yokoyama, M., and Nakamura, M. (1998). Proc. Natl. Acad. Sci. USA 95, 15659–15664.
Marsh, D. J., Hollopeter, G., Kafer, K. E., and Palmiter, R. D. (1998). Nat. Med. 4, 718–721.
Pedrazzini, T., Seydoux, J., Kunstner, P., et al. (1998). Nat. Med. 4, 722–726.
Pu, S., Dhillon, H., Moldawer, L. L., Kalra, P. S., and Kalra, S. P. (2000). J. Neuroendocrinol. 12, 827–832.
Sainsbury, A., Schwarzer, C., Couzens, M., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 8938–8943.
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K. (1999). Nature 402, 656–660.
Tschop, M., Smiley, D. L., and Heiman, M. L. (2000). Nature 407, 908–913.
Tschop, M., Wawarta, R., Riepl, R. L., et al. (2001). J. Endocrinol. Invest. 24, RC19-RC21.
Nakazato, M., Murakami, N., Date, Y., et al. (2001). Nature 409, 194–198.
Ahima, R. S., Saper, C. B., Flier, J. S., and Elmquist, J. K. (2000). Front. Neuroendocrinol. 21, 263–307.
Stephens, T. W., Basinski, M., Bristow, P. K., et al. (1995). Nature 377, 530–532.
Bagnasco, M., Kalra, P. S., and Kalra, S. P. (2002). Neuroendocrinology 75, 257–263.
Licinio, J., Negrao, A. B., Mantzoros, C., et al. (1998). Proc. Natl. Acad. Sci. USA 95, 2541–2546.
Dhillon, H., Kalra, S. P., Prima, V., et al. (2001). Regul. Pept. 99, 69–77.
Bagnasco, M., Dube, M. G., Kalra, P. S., and Kalra, S. P. (2002). Endocrinology 143, 4409–4421.
Dube, M. G., Beretta, E., Dhillon, H., Ueno, N., Kalra, P. S., and Kalra, S. P. (2002). Diabetes 51, 1729–1736.
Horvath, T. L., Diano, S., Sotonyi, P., Heiman, M., and Tschop, M. (2001). Endocrinology 142, 4163–4169.
Shintani, M., Ogawa, Y., Ebihara, K., et al. (2001). Diabetes 50, 227–232.
Willesen, M. G., Kristensen, P., and Romer, J. (1999). Neuroendocrinology 70, 306–316.
Bagnasco, M., Kalra, P. S., and Kalra, S. P. (2002). Endocrinology 143, 726–729.
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., and Weigle, D. S. (2001). Diabetes 50, 1714–1719.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalra, S.P., Kalra, P.S. Neuropeptide Y. Endocr 22, 49–55 (2003). https://doi.org/10.1385/ENDO:22:1:49
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:22:1:49